Speaker(s): 

Title: Treatment of Motor Fluctuations in Adult Patients with Advanced Parkinson's Disease

Learning Objectives:

1. Describe the mechanism of action, indication, and key features of foslevodopa/foscarbidopa, including its delivery system.
2. Review the efficacy and safety outcomes from pivotal and long-term clinical studies of foslevodopa/foscarbidopa.

At the conclusion of this session, the participant should be able to:

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Chichun Emily Sun DO and Karen Tillotson, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:

None.